PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmale breast neoplasms
MeSH D018567 - male breast neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001943:Breast neoplasms
191 Companies
84 Drugs
$
Success rate
D018567: 
Male breast neoplasms
1 Company
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
69%
49/71
Phase 2
20%
19/96
Phase 3
30%
11/37
Approved: 1Overall Success rate: 4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
Alpelisib,
Angiotensin ii,
Anthracycline,
Endocrine,
Lcz696
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use